| 1.8 |
5.4 |
GO:0046959 |
habituation(GO:0046959) |
| 1.5 |
4.6 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 1.4 |
4.2 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 1.1 |
3.4 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.9 |
2.8 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.9 |
3.5 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.9 |
2.6 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.8 |
1.7 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.8 |
3.3 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.8 |
0.8 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.8 |
2.4 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.8 |
2.3 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.8 |
2.3 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.7 |
4.3 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.7 |
2.8 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.7 |
2.1 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.7 |
0.7 |
GO:0050883 |
musculoskeletal movement, spinal reflex action(GO:0050883) |
| 0.7 |
2.6 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.6 |
0.6 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.6 |
1.2 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.6 |
2.5 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.6 |
18.0 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.6 |
3.0 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.6 |
1.8 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.6 |
3.0 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.6 |
2.9 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.6 |
2.9 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
| 0.6 |
1.7 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.6 |
2.2 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.5 |
2.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.5 |
7.5 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.5 |
2.5 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.5 |
3.0 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.5 |
7.9 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.5 |
3.4 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 0.5 |
1.5 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.5 |
1.4 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 0.5 |
1.4 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.5 |
2.3 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.5 |
1.9 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.4 |
1.3 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.4 |
1.3 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.4 |
2.6 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.4 |
0.9 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.4 |
7.2 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.4 |
0.8 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.4 |
3.3 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.4 |
2.1 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 |
1.2 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.4 |
0.4 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.4 |
1.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.4 |
3.6 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.4 |
1.2 |
GO:1904059 |
positive regulation of sensory perception of pain(GO:1904058) regulation of locomotor rhythm(GO:1904059) |
| 0.4 |
0.4 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.4 |
1.6 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 |
2.4 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.4 |
1.2 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.4 |
0.8 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.4 |
0.4 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 |
4.2 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.4 |
0.4 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.4 |
0.4 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.4 |
1.8 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.4 |
0.4 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.4 |
1.1 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.4 |
5.3 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.4 |
1.8 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.4 |
0.7 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.3 |
1.4 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.3 |
1.0 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.3 |
2.1 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.3 |
3.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.3 |
2.4 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.3 |
2.0 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.3 |
0.3 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.3 |
1.3 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.3 |
2.3 |
GO:0097324 |
melanocyte migration(GO:0097324) |
| 0.3 |
1.6 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.3 |
1.6 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.3 |
1.0 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 |
0.6 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.3 |
1.6 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.3 |
1.0 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 |
0.6 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.3 |
1.5 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 |
1.5 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.3 |
1.2 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.3 |
8.7 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.3 |
1.8 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.3 |
0.6 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.3 |
1.2 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.3 |
1.2 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 0.3 |
2.3 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.3 |
1.1 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 0.3 |
0.6 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.3 |
1.4 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.3 |
0.8 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.3 |
0.3 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 |
3.6 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.3 |
6.0 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.3 |
0.8 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.3 |
0.8 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.3 |
7.8 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.3 |
2.1 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 |
0.3 |
GO:0048489 |
synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
| 0.3 |
1.9 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.3 |
1.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.3 |
4.0 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.3 |
2.4 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.3 |
2.1 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.3 |
0.8 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.3 |
0.8 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.3 |
0.8 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 |
1.3 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.3 |
2.0 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.3 |
1.0 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.3 |
1.8 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.3 |
0.8 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 |
1.0 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.3 |
2.0 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 |
2.5 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.2 |
1.0 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.2 |
1.0 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.2 |
0.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 |
1.4 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.2 |
1.2 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.2 |
2.3 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.2 |
1.6 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.2 |
0.9 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.2 |
2.5 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.2 |
0.4 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.2 |
1.6 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.2 |
0.7 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.2 |
0.9 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.2 |
0.4 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 |
1.3 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.2 |
0.2 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.2 |
2.5 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.2 |
0.6 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.2 |
2.7 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.2 |
0.6 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.2 |
0.8 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 |
1.0 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.2 |
4.8 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 |
1.0 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.2 |
0.2 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 |
2.3 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.2 |
0.8 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.2 |
1.6 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.2 |
0.8 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
0.6 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.2 |
1.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.2 |
0.8 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.2 |
3.4 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 |
1.8 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.2 |
1.2 |
GO:1902805 |
positive regulation of synaptic vesicle transport(GO:1902805) |
| 0.2 |
0.2 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 |
0.6 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.2 |
1.0 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 |
0.6 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.2 |
0.8 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of receptor catabolic process(GO:2000645) |
| 0.2 |
1.3 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 |
0.4 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.2 |
0.6 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 |
0.4 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.2 |
1.7 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.2 |
0.9 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.2 |
0.2 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.2 |
0.7 |
GO:0014848 |
urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.2 |
1.8 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.2 |
0.5 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.2 |
1.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
0.5 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.2 |
0.7 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.2 |
0.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.2 |
2.0 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.2 |
6.4 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.2 |
2.0 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.2 |
1.1 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.2 |
0.4 |
GO:0009437 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.2 |
0.2 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 |
2.1 |
GO:0086011 |
membrane repolarization during action potential(GO:0086011) |
| 0.2 |
0.9 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
0.9 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.2 |
0.5 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 |
0.7 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.2 |
0.7 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.2 |
3.3 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.2 |
0.5 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.2 |
6.7 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.2 |
1.0 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.2 |
0.7 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.2 |
0.5 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 |
0.5 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.2 |
0.5 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.2 |
2.4 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.2 |
0.6 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.2 |
1.4 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.2 |
0.5 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.2 |
2.7 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.2 |
0.6 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
5.6 |
GO:0071242 |
cellular response to ammonium ion(GO:0071242) |
| 0.2 |
1.2 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
0.6 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.2 |
0.3 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.2 |
0.5 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.2 |
0.2 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.1 |
0.4 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 |
0.9 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
1.2 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
2.0 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.4 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.1 |
0.7 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 |
0.9 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.7 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.1 |
2.6 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
1.8 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.1 |
1.0 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 |
1.7 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.7 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
0.3 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
0.3 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.5 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
1.0 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.3 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 |
0.4 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.1 |
0.5 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.4 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.1 |
0.4 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.1 |
0.3 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.1 |
0.8 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.1 |
0.1 |
GO:0048550 |
negative regulation of pinocytosis(GO:0048550) |
| 0.1 |
0.4 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.5 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 |
0.4 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 |
0.4 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.1 |
0.5 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.5 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.1 |
0.3 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.5 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 |
3.2 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.1 |
0.3 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.1 |
0.3 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
0.5 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.5 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.1 |
0.9 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
1.2 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.6 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.1 |
0.9 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 |
0.2 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 |
1.0 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
0.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 |
0.4 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 |
0.1 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.7 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.1 |
0.9 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.8 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
0.2 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
1.9 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.1 |
0.3 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
0.2 |
GO:0061549 |
sympathetic ganglion development(GO:0061549) |
| 0.1 |
0.5 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.3 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 |
1.5 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.1 |
0.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
2.1 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 |
0.8 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 0.1 |
1.2 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.9 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.2 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.1 |
0.3 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.1 |
0.5 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
0.7 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.3 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.1 |
1.5 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.1 |
0.2 |
GO:1903242 |
regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
| 0.1 |
2.7 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.1 |
0.2 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 |
0.7 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.1 |
0.3 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.1 |
0.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.3 |
GO:2000650 |
negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.1 |
0.5 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
0.4 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.1 |
0.2 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.1 |
0.5 |
GO:0032305 |
positive regulation of icosanoid secretion(GO:0032305) |
| 0.1 |
0.8 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.1 |
0.3 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.1 |
0.6 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
2.3 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 |
2.6 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.1 |
0.4 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.1 |
2.0 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.1 |
2.3 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
0.6 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
0.1 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.1 |
2.2 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.1 |
1.1 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.1 |
0.3 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 |
0.3 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
0.2 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.1 |
1.7 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.6 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
0.1 |
GO:1904173 |
regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 0.1 |
0.5 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 |
0.4 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.1 |
0.6 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.7 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.1 |
0.4 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.1 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
4.2 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.1 |
0.4 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 |
0.1 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.3 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.1 |
0.6 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
0.6 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
0.9 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
0.4 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 |
0.3 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
0.4 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.1 |
1.4 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.4 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
0.3 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.4 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.1 |
0.3 |
GO:0032274 |
gonadotropin secretion(GO:0032274) |
| 0.1 |
0.1 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.1 |
0.5 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.1 |
0.4 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.2 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.1 |
0.5 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.1 |
0.3 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.7 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
0.2 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.1 |
1.1 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
0.3 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
1.9 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 |
0.3 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
0.2 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.3 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.1 |
0.4 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 |
0.6 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.2 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.1 |
0.2 |
GO:0010872 |
regulation of cholesterol esterification(GO:0010872) |
| 0.1 |
0.2 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
0.2 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 |
0.2 |
GO:0033700 |
phospholipid efflux(GO:0033700) |
| 0.1 |
0.7 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.4 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.6 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 |
0.5 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
0.2 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.1 |
0.7 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.3 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 |
0.6 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 |
0.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.9 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.7 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
0.3 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.7 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.1 |
0.1 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.1 |
0.4 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.1 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.1 |
1.2 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 |
1.5 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.1 |
0.4 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.1 |
0.1 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.1 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.1 |
0.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
0.3 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.1 |
0.1 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
0.7 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.1 |
0.4 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.4 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
1.0 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
0.8 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.1 |
0.2 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.1 |
0.1 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
| 0.1 |
0.5 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
1.5 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.1 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
0.5 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
0.2 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.1 |
0.8 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.3 |
GO:0051928 |
positive regulation of calcium ion transport(GO:0051928) |
| 0.1 |
0.3 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
0.5 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 |
0.1 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
4.3 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 |
0.8 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.1 |
0.4 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.5 |
GO:0060546 |
negative regulation of necroptotic process(GO:0060546) |
| 0.1 |
0.3 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.5 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.2 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 |
0.3 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.4 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.1 |
0.2 |
GO:0043312 |
neutrophil degranulation(GO:0043312) |
| 0.1 |
0.2 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
0.7 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.1 |
0.1 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.2 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.1 |
0.6 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.1 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.4 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.1 |
0.1 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.1 |
1.3 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.1 |
1.9 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.1 |
0.5 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 |
0.8 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.1 |
0.2 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.1 |
0.5 |
GO:0097576 |
autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.1 |
0.2 |
GO:0072201 |
negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.1 |
0.2 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.1 |
0.6 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.4 |
GO:1904707 |
regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
| 0.1 |
0.5 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.3 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.1 |
0.1 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
1.7 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.2 |
GO:0036230 |
granulocyte activation(GO:0036230) |
| 0.1 |
0.4 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.1 |
0.4 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.1 |
0.2 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.1 |
0.1 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.5 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.1 |
0.5 |
GO:0098907 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of AV node cell action potential(GO:0098904) regulation of SA node cell action potential(GO:0098907) |
| 0.1 |
0.2 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.2 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
1.6 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.1 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 |
0.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
0.4 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.1 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.1 |
0.6 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.1 |
0.4 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
0.2 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
0.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.9 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
0.1 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.0 |
0.2 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.1 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.0 |
0.2 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 |
0.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
2.2 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.4 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.1 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 |
0.2 |
GO:1903299 |
regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
| 0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.1 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.7 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.6 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.6 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
0.2 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.0 |
0.7 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.0 |
0.1 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.0 |
0.6 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.4 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.3 |
GO:0060509 |
Type I pneumocyte differentiation(GO:0060509) |
| 0.0 |
0.3 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
0.4 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 |
0.8 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.3 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
0.1 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.0 |
0.6 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.4 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.1 |
GO:0051798 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.0 |
0.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 |
0.9 |
GO:0046854 |
lipid phosphorylation(GO:0046834) phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.1 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.0 |
0.3 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.0 |
0.1 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.0 |
0.2 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.0 |
0.3 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.2 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.0 |
0.1 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.0 |
0.2 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.0 |
0.1 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 |
0.1 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.0 |
0.2 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.0 |
0.2 |
GO:0044532 |
modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) response to cycloheximide(GO:0046898) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.0 |
1.3 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.3 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.2 |
GO:2000189 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.0 |
0.8 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.0 |
GO:1900102 |
negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
| 0.0 |
1.3 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 |
0.1 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.0 |
0.2 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.0 |
0.3 |
GO:0050687 |
negative regulation of defense response to virus(GO:0050687) |
| 0.0 |
0.3 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.0 |
0.2 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.0 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.0 |
0.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.3 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.5 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.1 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 0.0 |
0.0 |
GO:0010752 |
dendritic cell antigen processing and presentation(GO:0002468) regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of dendritic cell antigen processing and presentation(GO:0002604) negative regulation of nitric oxide mediated signal transduction(GO:0010751) regulation of cGMP-mediated signaling(GO:0010752) |
| 0.0 |
0.1 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.0 |
0.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 |
0.6 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 |
0.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.2 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.0 |
0.1 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 |
0.2 |
GO:0038089 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.0 |
0.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.0 |
0.3 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.2 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.0 |
0.1 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.0 |
0.3 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.0 |
GO:0003347 |
epicardial cell to mesenchymal cell transition(GO:0003347) |
| 0.0 |
0.3 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.0 |
0.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.1 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.0 |
0.4 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.0 |
0.5 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.2 |
GO:2000543 |
positive regulation of gastrulation(GO:2000543) |
| 0.0 |
0.2 |
GO:0023021 |
termination of signal transduction(GO:0023021) termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.0 |
0.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.4 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.0 |
0.0 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 |
0.3 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.0 |
0.0 |
GO:0086005 |
ventricular cardiac muscle cell action potential(GO:0086005) |
| 0.0 |
0.1 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
1.1 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 |
0.1 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 |
0.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.2 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.0 |
0.9 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.1 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 |
0.3 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.0 |
0.5 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
0.1 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.0 |
0.5 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 |
1.0 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
1.6 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.1 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.0 |
0.2 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.0 |
0.1 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.2 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.0 |
0.1 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.2 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.2 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.1 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.0 |
0.2 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.0 |
0.3 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.0 |
0.0 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.0 |
0.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.2 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.0 |
0.1 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
| 0.0 |
0.2 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.2 |
GO:0002028 |
regulation of sodium ion transport(GO:0002028) |
| 0.0 |
0.6 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
| 0.0 |
0.2 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
2.4 |
GO:0071805 |
potassium ion transmembrane transport(GO:0071805) |
| 0.0 |
0.4 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.0 |
0.1 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.0 |
0.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 |
0.3 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
1.1 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.2 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.0 |
0.2 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.1 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.2 |
GO:0032965 |
regulation of collagen biosynthetic process(GO:0032965) |
| 0.0 |
0.1 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 |
0.4 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.2 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.0 |
0.1 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.0 |
0.1 |
GO:0033032 |
regulation of myeloid cell apoptotic process(GO:0033032) |
| 0.0 |
0.0 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.0 |
0.3 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.1 |
GO:0044110 |
growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.0 |
0.1 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) |
| 0.0 |
0.3 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.1 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.0 |
0.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.0 |
0.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.1 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.0 |
0.4 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:0046070 |
dGTP metabolic process(GO:0046070) |
| 0.0 |
0.1 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 |
0.2 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.0 |
0.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.1 |
GO:0034138 |
toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.0 |
0.4 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.6 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.3 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.0 |
GO:0098901 |
regulation of cardiac muscle cell action potential(GO:0098901) |
| 0.0 |
0.1 |
GO:0015909 |
long-chain fatty acid transport(GO:0015909) |
| 0.0 |
0.1 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.0 |
0.1 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 |
0.1 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 |
0.2 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.1 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.0 |
0.0 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.0 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
0.1 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.0 |
0.1 |
GO:0019935 |
cyclic-nucleotide-mediated signaling(GO:0019935) |
| 0.0 |
0.1 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 |
0.0 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.0 |
0.1 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.1 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.3 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 |
0.1 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
0.1 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.0 |
0.2 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.1 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.2 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 0.0 |
0.1 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.1 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.0 |
0.1 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.0 |
0.0 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.0 |
0.2 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.0 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.0 |
0.1 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.6 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.0 |
0.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.1 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.0 |
0.0 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.0 |
1.4 |
GO:0050890 |
cognition(GO:0050890) |
| 0.0 |
0.2 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.4 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.0 |
0.0 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.0 |
0.1 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.0 |
1.0 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.5 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.0 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 |
0.1 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
